FAU's Charles E. Schmidt College of Medicine has received approval for a University-sponsored residency program in neurology, in collaboration with Boca Raton Regional Hospital and Delray Medical Center.
Lawrence Toll, Ph.D., a renowned scientist whose research focuses on the management of pain and drug addiction through pharmacology and new drug discovery, recently joined FAU.
A researcher from the Schmidt College of Medicine is conducting a novel study to figure out if there is a unique genetic signature of patients who are most susceptible to prescription opioid-use disorder.
Randy Blakely, Ph.D. and Amy Wright, Ph.D. have been named NAI Fellows.
FAU has received a $1.3 million NIH grant for a "living" robot with its own nervous system. Researchers are creating a living pathway from the robot's touch sensation to the user's brain to help amputees.
A new study finds that the majority of hospice providers don't have end-of-life wishes themselves. Procrastination, fear of the subject and costs were reported as the most common barriers.
FAU's Charles E. Schmidt College of Medicine hosted a ribbon-cutting ceremony to observe the official launch of its newly expanded, 15,000-square-foot, state-of-the-art Clinical Skills Simulation Center.
The first economic study on frontotemporal degeneration (FTD), the most common dementia for people under age 60, shows that FTD inflicts a much more severe burden on families than Alzheimer's disease.
The "Dementia Prevention Initiative" abandons generalized methods used to research and treat Alzheimer's disease. The secret weapon: a novel "N-of-1 design" that personalizes medicine down to a single patient.
A $2.3 million National Institutes of Health grant will help FAU neuroscientists to continue research to better understand and treat several neuropsychiatric disorders including depression and autism.